VaxInnate Logo

04/04/2013

VaxInnate Awarded U.S. Government Grant to Develop  

Mosquito-borne disease identified  

      Read More

 

01/16/2013

VaxInnate’s License Agreement with Emergent BioSolutions  

Improves U.S. Preparedness  

      Read More


09/04/2012

Two New Executives Join VaxInnate Management Team  

VaxInnate Corporation announced  

      Read More

 
All news


VaxInnate is developing novel, proprietary vaccines for pandemic and seasonal influenza.
Using our proven technology platform, VaxInnate has the potential to produce potent vaccines for a range of infectious diseases and help meet urgent public health needs.










Vaccine

Currently marketed influenza vaccines are based on a development, production and vaccination strategy that ...


Toll-Like Receptor (TLR)

VaxInnate's TLR technology is based on the ability of "toll-like receptors" (TLRs) to recognize certain molecular patterns...


Background Biology

The immune system takes two different, yet interdependent approaches to defeating a foreign pathogen...

All technologies
VaxInnate Employees

©2012 VaxInnate, Inc.  |  Legal  |  Privacy